Image of Jennifer Doudna speaking

GSK partners with CRISPR pioneer Doudna to search for new drugs

The drug maker GlaxoSmithKline announced Thursday that it would team up with some of the nation’s most prominent CRISPR researchers to use the gene-editing technology in a search for new medicines, establishing a new lab in San Francisco and spending up to $67 million over five years.

Jennifer Doudna, the University of California, Berkeley, researcher who co-invented the CRISPR enzyme technology, will help lead the effort, along with Jonathan Weissman, a UC San Francisco researcher who has been using CRISPR to understand the function of individual human genes and how they work together. Both are Howard Hughes Medical Institute investigators.

Focus

CRISPR

Client

UC Berkeley

READ THE ARTICLE

 

This is a unique website which will require a more modern browser to work!

Please upgrade today!